NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

With the MAA acceptance -validation cacophony now put to bed , let's move into the nwbo stock price.

Today , one of our md-phd friends reportded in. He's chomping at the bit to have his prostate cancer clinic get on with a DCV VAX L-prostate trial .They are studying () to pick the best combo.

This is a hoot.

DCVax-Prostate had the P3 IND approved by 2001. 23 years ago. It has been up for partnership for over a decade with no takers.

If it was even close to what longs asserted for those decades somebody would have ponied up some cash to run with it.

Also, it is not a "-L", I would think a phd in this field could see that. Not even clear if a -L variant could be made based on the fact that typically at that stage there is no surgery (bulk removal occurs way earlier, and often not surgery).

Per NWBO:

DCVax®-Prostate is designed specifically for late stage, hormone independent prostate cancer. Such cancer involves the spread of micro-metastases beyond the prostate tissue. In most patients, there is no focal tumor which can be surgically removed and used to make lysate, or into which dendritic cells can be directly injected.

Anybody hyping a drug that has litterally been shelved for 22 years after having a P3 IND ready to run is an idiot.